Influence of Gum Disease Treatment on Long-term Dental Implant Success
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03841656 |
|
Recruitment Status : Unknown
Verified February 2019 by University Hospital, Strasbourg, France.
Recruitment status was: Not yet recruiting
First Posted : February 15, 2019
Last Update Posted : February 15, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Periodontitis | Procedure: PARORISKIMPLANT |
| Study Type : | Observational |
| Estimated Enrollment : | 200 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | Influence of Periodontal Care Response on Implant Treatment Outcomes at Long-term |
| Estimated Study Start Date : | March 1, 2019 |
| Estimated Primary Completion Date : | March 1, 2022 |
| Estimated Study Completion Date : | March 1, 2022 |
- Procedure: PARORISKIMPLANT
Patients attending periodontal and implant treatment at the Department of Periodontology of the Dental Faculty at Strasbourg, France, between 2000-2015.
- Presence of peri-implantitis as measured by probing depth [ Time Frame: At least 3 years after dental implant placement ]The implant has a probing depth more than or equal to 4 mm
- Presence of peri-implantitis as measured by erythema [ Time Frame: At least 3 years after dental implant placement ]The implant has bleeding on probing
- Presence of peri-implantitis as measured by radiographic bone loss [ Time Frame: At least 3 years after dental implant placement ]The implant has a radiographic bone loss when compared to previous radiographs
- Implant survival [ Time Frame: At least 3 years after dental implant placement ]presence of implant on arch Peri-implant mucositis: presence of bleeding on probing
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
Patient attending supporting periodontal therapy with at least one implant placed for more than 3 years
- Patient with more than 12 teeth at baseline
- Patient with demographic, periodontal, implant data recording
- patient aged >30 years at Baseline
Exclusion criteria:
- Patient needed antibiotic prophylaxis
- Uncontrolled diabetes
- Systemic inflammatory or autoimmune diseases
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03841656
| Contact: Olivier HUCK | 00333 ext 116947 | olivier.huck@chru-strasbourg.fr |
| Responsible Party: | University Hospital, Strasbourg, France |
| ClinicalTrials.gov Identifier: | NCT03841656 |
| Other Study ID Numbers: |
67RC001 |
| First Posted: | February 15, 2019 Key Record Dates |
| Last Update Posted: | February 15, 2019 |
| Last Verified: | February 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Periodontitis Periodontal Diseases Mouth Diseases Stomatognathic Diseases |

